What are the recommended preoperative assessment, surgical approach, mesh type, perioperative prophylaxis, postoperative management, and follow‑up for a 66‑year‑old woman undergoing sacrocolpopexy?

Recommendations for Sacrocolpopexy in a 66-Year-Old Female

For a 66-year-old woman undergoing sacrocolpopexy, pursue a minimally invasive approach (laparoscopic or robotic) with Type 1 polypropylene mesh, provide single-dose preoperative antibiotics within 60 minutes of incision, consider mechanical bowel preparation for improved postoperative bowel function, and implement dual VTE prophylaxis (mechanical plus pharmacologic) for procedures lasting >30 minutes.

Preoperative Assessment

Patient Optimization

• Avoid routine pubic hair removal; if necessary, clip rather than shave to minimize infection risk 1
• Consider preoperative vaginal estrogen in postmenopausal women, though evidence for improved surgical outcomes is limited 1
• Provide written preoperative education materials, which are superior to verbal instruction alone for patient satisfaction and potentially shorter hospital stays 1

Bowel Preparation

Consider mechanical bowel preparation (MBP) before minimally invasive sacrocolpopexy 1. While MBP shows no benefit for infection rates or anastomotic leaks in most gynecologic surgery, an RCT specifically demonstrated that women undergoing minimally invasive sacrocolpopexy who received MBP had improved postoperative defecatory function and better surgeon perceptions of the surgical field 1. Enemas are a reasonable alternative to reduce stool burden without adverse effects on recovery 1.

Surgical Approach

Minimally Invasive Technique Preferred

Strongly recommend laparoscopic or robotic-assisted sacrocolpopexy over open approach 2, 3. The evidence supports:

• Robotic-assisted sacrocolpopexy shows anatomical success rates of 87.5% with low complication rates (9% intraoperative complications) 2
• Single-port robotic approach reduces operative time by 40 minutes compared to multi-port (176 vs 216 minutes) with similar safety profiles 3
• Long-term data (12 years) demonstrates 81% subjective success with only 19% reporting bulge symptoms 4

Age Considerations

Age ≥70 years is NOT a contraindication to sacrocolpopexy 5. Women aged 70+ undergoing minimally invasive sacrocolpopexy have:

• No increased risk of perioperative adverse events compared to younger patients
• Actually 73% lower odds of surgical site infections
• Equivalent prolapse recurrence and mesh complication rates 5

For this 66-year-old patient, age should not influence the decision to proceed with standard minimally invasive sacrocolpopexy.

Mesh Selection

Use Type 1 polypropylene mesh 6. Current literature supports Type 1 mesh (macroporous, monofilament) as the standard for sacrocolpopexy, though this is based on level 2 evidence. Recent data using polyvinylidene fluoride (PVDF) mesh shows:

• Zero apical recurrences at 12 months
• 4.4% cumulative mesh erosion rate
• 93% patient satisfaction 7

Mesh Configuration

Consider both anterior and posterior mesh placement rather than anterior-only approach 8. A recent case report highlights that anterior-only sacrocolpopexy can result in obstructive enterocele requiring reoperation. While compartment-specific approaches exist, be vigilant for posterior compartment weakness.

Perioperative Prophylaxis

Antimicrobial Prophylaxis

Administer single-dose IV antibiotics within 60 minutes before incision 1. While evidence for vaginal surgery without hysterectomy is less robust, 93% of surgeons use antibiotic prophylaxis when mesh is involved in prolapse surgery 1. Given mesh placement in sacrocolpopexy, prophylactic antibiotics are strongly recommended despite the clean-contaminated classification.

VTE Prophylaxis

Implement dual prophylaxis: mechanical (sequential compression devices) plus pharmacologic (LMWH or UFH) for procedures >30 minutes 1. The rationale:

• Benign vaginal surgeries have VTE rates <1%, with vaginal approaches showing the lowest rate (0.17%) 1
• However, sacrocolpopexy involves longer operative times and abdominal approach considerations
• Initiate prophylaxis preoperatively and continue throughout hospital stay 1

Specific dosing considerations 9:

• Low molecular weight heparin (enoxaparin, dalteparin, or tinzaparin)
• Contraindications: active bleeding, thrombocytopenia with positive antiplatelet antibodies, severe renal impairment
• Monitor for hemorrhage, thrombocytopenia, and elevated liver enzymes

Postoperative Management

Hospital Stay

Expect median hospital stay of 3-5 days for standard laparoscopic approach 7, though robotic single-port approaches may achieve discharge in 11-17 hours 3. Early mobilization is essential.

Complications to Monitor

Intraoperative complications (9%) include 2:

• Bowel serosal abrasion
• Bladder wall injuries
• Trocar site bleeding
• Subcutaneous emphysema
• Retroperitoneal hematoma

Early postoperative complications correlate with higher grade of prolapse and occur in approximately 10% of cases 4.

Mesh-Related Complications

Mesh erosion occurs in 3-4.4% of cases 7, 4, with important timing considerations:

• All mesh erosions in one long-term study occurred after the 5th postoperative year 4
• Only 2.2% require surgical revision 7
• Vigilance for mesh complications must extend beyond the immediate postoperative period

Follow-Up Protocol

Timing

Structure follow-up at:

• 8 weeks postoperatively (FU2)
• 6 months postoperatively (FU3)
• 12 months postoperatively (FU4) 7

Outcomes Assessment

Monitor for:

• Apical recurrence (defined as POP-Q ≥ grade II)
• De novo urinary symptoms: Urge incontinence is the most common new symptom, followed by stress incontinence 4
• Mesh erosion: Examine vaginal mucosa carefully at each visit
• Bowel dysfunction: Incomplete emptying, constipation, or obstructive symptoms 8

Success Rates

Expected outcomes at 12 months:

• Zero apical recurrences in recent series 7
• 93-94% patient satisfaction 7
• 10.4% reoperation rate at medium-term follow-up 2

Long-Term Surveillance

Continue annual follow-up given that mesh erosions can occur after 5 years 4. At 12-year follow-up, 81% of patients report satisfaction despite 19% experiencing subjective recurrence 4.

Key Pitfalls to Avoid

1. Do not withhold surgery based on age alone: Women ≥70 have equivalent or better outcomes 5
2. Do not skip mechanical bowel preparation: Unlike other gynecologic procedures, MBP specifically benefits sacrocolpopexy patients 1
3. Do not use anterior-only mesh without careful assessment: Risk of obstructive enterocele 8
4. Do not assume mesh complications only occur early: Erosions can present years after surgery 4
5. Do not forget VTE prophylaxis: Despite low baseline VTE rates in vaginal surgery, the abdominal approach and longer operative times warrant dual prophylaxis 1